Trial · NCT02802449
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Plasma PTH Level | Placebo | Baseline | 58.29 | Standard Deviation 23.82 | pg/ml |
| Plasma PTH Level | 25 Hydroxy-Vitamin D3 or [25 (OH) D3] | Baseline | 60.73 | Standard Deviation 26.04 | pg/ml |
| Plasma PTH Level | Placebo | Week 6 | 57.88 | Standard Deviation 22.23 | pg/ml |
| Plasma PTH Level | 25 Hydroxy-Vitamin D3 or [25 (OH) D3] | Week 6 | 54.05 | Standard Deviation 26.12 | pg/ml |
| Vitamin D3 Level | Placebo | Baseline | 17.02 | Standard Deviation 4.51 | ng/ml |
| Vitamin D3 Level | 25 Hydroxy-Vitamin D3 or [25 (OH) D3] | Baseline | 16.55 | Standard Deviation 4.87 | ng/ml |
| Vitamin D3 Level | Placebo | Week 6 | 16.64 | Standard Deviation 4.90 | ng/ml |
| Vitamin D3 Level | 25 Hydroxy-Vitamin D3 or [25 (OH) D3] | Week 6 | 32.73 | Standard Deviation 7.14 | ng/ml |
| Oxidative Stress Markers: Cysteine | Placebo | Cysteine (Baseline) | 253.5 | Standard Deviation 41.5 | umol/L |
| Oxidative Stress Markers: Cysteine | 25 Hydroxy-Vitamin D3 or [25 (OH) D3] | Cysteine (Baseline) | 252.4 | Standard Deviation 35.6 | umol/L |
| Oxidative Stress Markers: Cysteine | Placebo | Cysteine (Week 6) | 249.0 | Standard Deviation 38.7 | umol/L |
| Oxidative Stress Markers: Cysteine | 25 Hydroxy-Vitamin D3 or [25 (OH) D3] | Cysteine (Week 6) | 241.2 | Standard Deviation 32.8 | umol/L |
| Oxidative Stress Markers: Homocysteine | Placebo | Homocysteine (Baseline) | 11.5 | Standard Deviation 3.3 | umol/L |
| Oxidative Stress Markers: Homocysteine | 25 Hydroxy-Vitamin D3 or [25 (OH) D3] | Homocysteine (Baseline) | 11.9 | Standard Deviation 6.1 | umol/L |
| Oxidative Stress Markers: Homocysteine | Placebo | Homocysteine (Week 6) | 11.0 | Standard Deviation 3.0 | umol/L |
| Oxidative Stress Markers: Homocysteine | 25 Hydroxy-Vitamin D3 or [25 (OH) D3] | Homocysteine (Week 6) | 11.8 | Standard Deviation 4.8 | umol/L |
| Oxidative Stress Markers: GSH | Placebo | GSH (Baseline) | 4.1 | Standard Deviation 1.2 | umol/L |
| Oxidative Stress Markers: GSH | 25 Hydroxy-Vitamin D3 or [25 (OH) D3] | GSH (Baseline) | 4.1 | Standard Deviation 1.1 | umol/L |
| Oxidative Stress Markers: GSH | Placebo | GSH (Week 6) | 3.6 | Standard Deviation 0.9 | umol/L |
| Oxidative Stress Markers: GSH | 25 Hydroxy-Vitamin D3 or [25 (OH) D3] | GSH (Week 6) | 3.5 | Standard Deviation 0.8 | umol/L |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02802449/results